期刊文献+

玻璃体腔注射康柏西普联合Ahmed青光眼引流阀植入和视网膜光凝治疗新生血管性青光眼 被引量:12

Intravitreal Injection of Conbercept Combined with Ahemd Glaucoma Valve Implants and Panretinal Photocoagulation Treatment for Neovascular Glaucoma
原文传递
导出
摘要 目的:探讨玻璃体腔注射康柏西普联合Ahmed青光眼引流阀植入和视网膜光凝对新生血管性青光眼(NVG)的治疗效果。方法:回顾性研究。分析2017年6月至2018年6月于空军986医院眼科就诊的NVG患者16例(17眼),先行玻璃体腔注射康柏西普0.05 ml,再行Ahmed青光眼引流阀植入术,后择机行视网膜激光光凝,观察治疗前后视力、新生血管、眼压等情况。数据采用连续测量方差分析比较。术后各时间点眼压与术前比较采用独立样本t检验。结果:注药后3 d新生血管明显萎缩,1个月时,17眼新生血管全部消退。治疗前眼压为(43.3±7.6)mmHg(1 mmHg=0.133 kPa),联合治疗后3 d眼压为(14.8±4.8)mmHg,7 d时眼压为(13.7±3.9)mmHg,1个月时为(14.5±4.6)mmHg,3个月时为(13.6±5.4)mmHg,6个月时为(13.9±4.6)mmHg,不同时间点的眼压比较差异有统计学意义(F=9.58,P=0.006)。治疗后各个时间点眼压与治疗前相比差异均有统计学意义(P<0.05)。联合治疗后较治疗前,最佳矫正视力提高5眼。结论:玻璃体腔注射康柏西普联合Ahmed青光眼引流阀植入和视网膜光凝治疗NVG安全有效。 Objective:To observe the clinical effects of intravitreal injection of conbercept combined with Ahemd glaucoma valve implant and panretinal photocoagulation treatment for neovascular glaucoma(NVG).Methods:In this retrospective case series study,16 NVG patients(17 eyes),at the Number 986 Hospital of the Air Force,were treated from June,2017 to June,2018 with intravitreal injection of conbercept combined with Ahemd glaucoma valve implants and panretinal photocoagulation.The disappearance of neovascularization,intraocular pressure(IOP)and best corrected visual acuity(BCVA)were compared between preoperative and postoperative conditions.The data were analyzed by repeated measures ANOVA.The IOP between preoperative and every follow-up was analyzed with independent sample t test Results:After injection,neovascularization was greatly diminshed by 3 d,and completely vanished by 1 month.The preoperative IOP was 43.3±7.6 mmHg,and postoperative IOP was 14.8±4.8 mmHg,13.7±3.9 mmHg,14.5±4.6 mmHg,13.6±5.4 mmHg and 13.9±4.6 mmHg at 3 d,7 d,1 month,3 months,and 6 months,respectively.There were no significant differences in IOP at different postoperative time points(F=9.58,P=0.006).Compared with preoperative levels,there were significant differences at every followup(P<0.05).Compared with preoperative measurements,the BCVA of 5 eyes improved.Conclusions:Intravitreal injection of conbercept combined with Ahemd glaucoma valve implants and panretinal photocoagulation is a safe and effective treatment for neovascular glaucoma.
作者 海鸥 刘芳 高丹宇 Ou Hai;Fang Liu;Danyu Gao(The Number 986 Hospital of the Air Force,Xi'an 710018,China)
机构地区 空军
出处 《中华眼视光学与视觉科学杂志》 CAS CSCD 2019年第11期838-841,共4页 Chinese Journal Of Optometry Ophthalmology And Visual Science
关键词 新生血管性青光眼 康柏西普 Ahmed青光眼引流阀植入 视网膜光凝 玻璃体腔注射 neovascular glaucoma conbercept Ahemd glaucoma valve panretinal photocoagulation intravitreal injection
  • 相关文献

参考文献6

二级参考文献70

  • 1Mahmut Kaya,Zeynep Ozbek,Aylin Yaman,Ismet Durak.Long-term success of ahmed glaucoma valve in refractory glaucoma[J].International Journal of Ophthalmology(English edition),2012,5(1):108-112. 被引量:15
  • 2陈虹,张舒心,刘磊,林丁,唐炘,孙丽,王涛,王华,王宁利.Ahmed青光眼阀植入术的中远期疗效评价[J].中华眼科杂志,2005,41(9):796-802. 被引量:58
  • 3杨侠,董晓光.Ahmed青光眼阀治疗难治性青光眼的作用和现状[J].国际眼科杂志,2005,5(5):994-998. 被引量:34
  • 4Shazly TA, Latina MA. Neovascular glaumma: etiology, diagnosis and prognosis [ J ]. Semin Ophthalmo1,2009 ,24 ( 2 ) : 113-121.
  • 5Sasamoto Y, Oshima Y, Miki A, et al. Clinical outcomes and changes in aqueous vascular endothelial growth factor levels after intravitreal bevacizumab for iris neovascularization and neovascular glancoma:a retrospective two-dose comparative study [ J ]. J Ocul Pharmacol Ther,2012,28 ( 1 ) :41 48.
  • 6Weiss DI, Shaffer RN, Nehernberg TR. Neovascular glaucoma com- plicating carotid-cavernous fistula [ j ]. Arch Ophthalmol, 1963,69 ( 3 ) :304-307.
  • 7Sivak-Callcott JA, O' Day DM, Gass JD,et al. Evidence based rec- ommendations for the diagnosis and treatment of neovascular glau- coma [ J ]. Ophthamlology,2001,108 ( 10 ) : 1767-1776.
  • 8Ciulla TA, Rosenfeld PJ. Antivascular endothelial growth factor therapy for neovascular age-related macular degeneration [ J 1. Curr Opin Ophthamlol, 2009,20 ( 3 ) : 158-165.
  • 9Storkebaum E, Lambrechts D, Carmeliet P. VEGF:once regarded as a specific angiogenic factor, now implicated in neuroprotection [ J ]. Bioessays,2004,26 ( 4 ) :943-954.
  • 10Ferrara N, Gerber HP, Le Couter J. The biology of VEFG and its receptors [ J ]. Nat Med, 2003,9 ( 6 ) : 669-676.

共引文献45

同被引文献122

引证文献12

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部